Darwin AG's (MUN:7V0) Price Is Right But Growth Is Lacking
Jul 06
Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedAug 14, 2025
DataAggregated Company Financials
Companies17
- 7D-0.9%
- 3M0.1%
- 1Y-7.0%
- YTD-4.3%
Over the last 7 days, the Biotech industry has dropped 2.0%, driven by a pullback from Darwin of 9.6%. However, the industry is down 7.6% over the past year. Earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 14 Aug 2025 | €3.4b | €774.6m | -€184,922,260.59 | 3.5x | -18.3x | 4.4x |
| Sat, 12 Jul 2025 | €2.4b | €772.7m | -€178,999,093.00 | 3.9x | -13.2x | 3x |
| Mon, 09 Jun 2025 | €2.3b | €772.7m | -€178,999,093.00 | 4.1x | -12.9x | 3x |
| Wed, 07 May 2025 | €2.2b | €836.4m | -€143,205,717.00 | 24.2x | -15.4x | 2.6x |
| Fri, 04 Apr 2025 | €2.2b | €818.3m | -€158,085,276.00 | 29.6x | -14x | 2.7x |
| Sun, 02 Mar 2025 | €2.3b | €791.9m | €72.9m | 13.8x | 31.2x | 2.9x |
| Tue, 28 Jan 2025 | €2.7b | €791.8m | €74.2m | 14.6x | 36.6x | 3.4x |
| Thu, 26 Dec 2024 | €2.6b | €791.8m | €74.2m | 14.5x | 35.2x | 3.3x |
| Sat, 23 Nov 2024 | €2.5b | €791.8m | €74.2m | 12.9x | 34.3x | 3.2x |
| Mon, 21 Oct 2024 | €2.7b | €866.1m | €170.2m | 11.9x | 15.8x | 3.1x |
| Wed, 18 Sep 2024 | €2.6b | €867.2m | €174.8m | 12.2x | 14.9x | 3x |
| Fri, 16 Aug 2024 | €2.6b | €867.0m | €171.1m | 14.2x | 15.1x | 3x |
| Sun, 14 Jul 2024 | €2.7b | €885.2m | €215.0m | 12.8x | 12.7x | 3.1x |
| Tue, 11 Jun 2024 | €2.6b | €884.7m | €210.7m | 11.7x | 12.5x | 3x |
| Thu, 09 May 2024 | €2.6b | €884.7m | €210.7m | 9.9x | 12.1x | 2.9x |
| Sat, 06 Apr 2024 | €5.2b | €1.0b | -€179,347,058.40 | 9.1x | -29.1x | 5.2x |
| Mon, 04 Mar 2024 | €2.7b | €746.1m | -€35,822,108.00 | 12.5x | -74x | 3.6x |
| Wed, 31 Jan 2024 | €2.8b | €769.9m | -€145,885,802.00 | 13x | -19.1x | 3.6x |
| Fri, 29 Dec 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.6x | -17.8x | 3.7x |
| Sun, 26 Nov 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.6x | -18.1x | 3.7x |
| Tue, 24 Oct 2023 | €3.6b | €955.3m | -€172,995,145.00 | 10x | -21x | 3.8x |
| Thu, 21 Sep 2023 | €4.0b | €971.6m | -€197,588,171.00 | 11.6x | -20.2x | 4.1x |
| Sat, 19 Aug 2023 | €4.0b | €947.8m | -€36,632,772.00 | 19x | -109.8x | 4.2x |
| Mon, 17 Jul 2023 | €4.0b | €955.7m | -€219,213,323.00 | 26.2x | -18.2x | 4.2x |
| Wed, 14 Jun 2023 | €4.1b | €967.4m | -€212,660,026.00 | 30.2x | -19.4x | 4.3x |
| Fri, 12 May 2023 | €3.7b | €967.4m | -€209,726,026.00 | 29.9x | -17.6x | 3.8x |
| Sun, 09 Apr 2023 | €3.5b | €920.1m | -€215,175,409.00 | 13.6x | -16.5x | 3.9x |
| Tue, 07 Mar 2023 | €2.9b | €612.1m | -€74,398,465.00 | 10.2x | -39.3x | 4.8x |
| Thu, 02 Feb 2023 | €3.0b | €611.9m | -€53,407,435.00 | 10.6x | -55.5x | 4.8x |
| Sat, 31 Dec 2022 | €3.0b | €611.9m | -€53,407,435.00 | 11.1x | -56.5x | 4.9x |
| Mon, 28 Nov 2022 | €3.0b | €611.9m | -€53,407,435.00 | 11.1x | -56.4x | 4.9x |
| Wed, 26 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.9x | -19.9x | 4.1x |
| Fri, 23 Sep 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.2x | -19.8x | 4.1x |
| Sun, 21 Aug 2022 | €2.8b | €605.7m | -€150,021,513.00 | 6.3x | -18.6x | 4.6x |
Price to Earnings Ratio
-18.6x
Current Industry PE
- Investors are optimistic on the German Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 3.7x is lower than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 8.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -1.15% | |
| Healthcare | 4.33% | |
| Biotech | -0.88% | |
| Biotech | -0.88% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HPHA Heidelberg Pharma | €4.48 | 8.0% +€15.4m | 82.9% | PS49.9x | |
| VSC 4SC | €0.52 | 23.7% +€1.1m | -87.0% | PS16.5x | |
| 20B Biomark Diagnostics | €0.21 | 2.0% +€420.4k | 60.9% | PS226x | |
| MDG1 Medigene | €0.079 | 24.9% +€235.2k | -96.7% | PS0.2x | |
| T5O0 bioXXmed | €0.40 | 14.3% +€25.7k | -82.5% | PS41.2x |